Analysts’ Recent Ratings Changes for Ventas (VTR)

Several brokerages have updated their recommendations and price targets on shares of Ventas (NYSE: VTR) in the last few weeks:

• 9/15/2026 – Ventas is now covered by Jefferies Financial Group Inc.. They set a “buy” rating and a $102.00 price target on the stock.
• 9/15/2026 – Ventas is now covered by Jefferies Financial Group Inc.. They set a “buy” rating and a $102.00 price target on the stock.
• 9/2/2026 – Ventas had its price target raised by Scotiabank from $93.00 to $95.00. They now have a “sector perform” rating on the stock.
• 9/1/2026 – Ventas had its price target raised by Wells Fargo & Company from $96.00 to $104.00. They now have an “overweight” rating on the stock.
• 8/31/2026 – Ventas had its price target raised by Barclays PLC from $99.00 to $102.00. They now have an “equal weight” rating on the stock.
• 8/14/2026 – Ventas had its price target raised by Royal Bank Of Canada from $98.00 to $99.00. They now have an “outperform” rating on the stock.
• 8/11/2026 – Ventas had its price target raised by BMO Capital Markets from $105.00 to $107.00. They now have an “outperform” rating on the stock.
• 8/4/2026 – Ventas had its price target raised by Citigroup Inc. from $100.00 to $110.00. They now have a “buy” rating on the stock.
• 7/31/2026 – Ventas had its price target raised by Cantor Fitzgerald from $97.00 to $102.00. They now have an “overweight” rating on the stock.
• 7/22/2026 – Ventas had its price target raised by Mizuho from $98.00 to $104.00. They now have an “outperform” rating on the stock.
• 7/21/2026 – Ventas was upgraded by Weiss Ratings from “hold (c+)” to “buy (b-)”.

Ventas Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Wednesday, September 30th will be given a dividend of $0.52 per share. The ex-dividend date is Wednesday, September 30th. This represents a $2.08 annualized dividend and a yield of 2.4%. Ventas’s dividend payout ratio (DPR) is 385.19%.

Ventas, Inc is a real estate investment trust (REIT) that owns and manages a diversified portfolio of healthcare and senior living properties. Its real estate platform includes senior housing communities, medical office buildings, life science and innovation centers, and other healthcare-related facilities.

The company generally leases or operates its properties through relationships with healthcare providers, senior living operators, universities, and research institutions. Its properties support services such as independent and assisted living, skilled nursing, outpatient care, physician practices, medical research, and biotechnology development.

Ventas serves major healthcare and life science markets in the United States and Canada.